Myocardial ischemic activation of the Akt pathway
Myocardial ischemic activation of the Akt pathway
批准号:
6938597
负责人:
STEPHEN C ARMSTRONG
金额:
$27.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-16 至 2008-06-30
关键词:
G protein coupled receptor kinaseapoptosisbiological signal transductioncardiac myocytescytoprotectionendocytosisfocal adhesion kinasegel mobility shift assayheat shock proteinsimmunofluorescence techniqueimmunoprecipitationischemic preconditioninglaboratory rabbitnuclear factor kappa betaphosphatidylinositol 3 kinasephosphorylationprotein protein interactionwestern blottings
中文摘要
描述(由申请人提供):PI-3激酶/Akt通路是预处理提供的心脏保护的潜在介质。本提案的主要目的是鉴定由PI-3激酶/Akt通路激活的心脏保护性末端效应物。热休克因子-1(HSF-1)是一种转录因子,可启动热休克蛋白70(HSP 70)的表达,HSP 70是一种分子伴侣,与缺血预处理提供的心脏保护有关。NFkB在缺血预处理中的作用也已得到证实。HSF-1和NFkB的活化受GSK-3的负调节,并且这种调节被Akt对糖原合成酶激酶(GSK)-3b的磷酸化所消除。将确定GSK-3在抑制HSF-1和NF κ B中的相对作用。我们还将研究另一种Akt底物凋亡信号调节激酶1(ASK 1)。我们将确定Akt与ASK-1的关联以及随后Akt介导的ASK-1在Ser 83处的磷酸化,负性调节p38 MAPK和Jun激酶的激活以及凋亡的启动。这可能涉及ASK 1与14-3-3蛋白的相互作用。我们还将研究Akt与小的热休克蛋白HSP 27的关系,HSP 27作为Akt的支架蛋白。我们将确定HSP 27与Akt联合促进Akt抗凋亡功能的能力。在心肌缺血期间启动PI-3激酶活化并调节Akt活性的信号通路尚未阐明。肌细胞中肌营养不良蛋白聚糖复合物的破坏减少Akt和GSK-3磷酸化,引发细胞凋亡。我们提出,b-肌营养不良蛋白聚糖(bDG)组装一个信号分子的复合物,允许与PI-3 K的p85亚基的关联和激活,启动Akt磷酸化。我们提出PI-3激酶/Akt激活需要与bDG复合物相关的膜的内吞作用。这类似于最近的报道,缺血预处理是由内体G蛋白偶联受体激活途径介导的。这些研究将有助于从分子水平了解不可逆缺血性心肌损伤的机制和预适应的终末效应。这可能允许开发用于治疗延迟心肌缺血和保护受梗死危害的心肌的药理学方式。
英文摘要
DESCRIPTION (provided by applicant): The PI-3 kinase/Akt pathway is a potential mediator of the cardioprotection provided by preconditioning. The primary purpose of this proposal is the identification of the cardioprotective end-effectors that are activated by the PI-3 kinase/Akt pathway. Heat shock factor-1 (HSF-1) is a transcription factor that initiates the expression of heat shock protein 70 (HSP70), a molecular chaperone that has been associated with the cardioprotection provided by ischemic preconditioning. A role for NFkB in ischemic preconditioning has also been demonstrated. HSF-1 and NFkB activation are negatively regulated by GSK-3 and this regulation is abrogated by the phosphorylation of glycogen synthase kinase (GSK)-3b by Akt. The relative role of GSK-3 in the inhibition of HSF-1 and NFkB will be determined. We will also examine an alternative Akt substrate apoptosis signal regulating kinase 1 (ASK1). We will determine the association of Akt with ASK1 and the subsequent Akt mediated phosphorylation of ASK-1 at Ser83, negatively regulating the activation of p38MAPK and Jun kinase and the initiation of apoptosis. This might involve the interaction of ASK1 with 14-3-3 protein. We will also examine the association of Akt with the small heat shock protein, HSP27, which functions as a scaffolding protein for Akt. We will determine the ability of HSP27, in association with Akt, to facilitate the anti-apoptotic function of Akt. The signaling pathways that initiate PI-3 kinase activation during myocardial ischemia and regulate Akt activity have not been elucidated. Disruption of the dystroglycan complex in muscle cells decreases Akt and GSK-3 phosphorylation, initiating apoptosis. We propose that b-dystroglycan (bDG) assembles a complex of signaling molecules that allows an association with and activation of the p85 subunit of PI-3K, initiating Akt phosphorylation. We propose that PI-3 kinase/Akt activation requires endocytosis of this membrane associated the bDG complex. This is analogous to the recent report that ischemic preconditioning is mediated by an endosomal G-protein coupled receptor activation pathway. These studies will afford a molecular understanding of the mechanisms of irreversible ischemic myocardial injury and the end effectors of preconditioning. This may allow the development of pharmacologic modalities for the therapeutic delay of myocardial ischemia and the preservation of myocardium jeopardized by infarction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INCREASED A7/B1 INTEGRIN SIGNALING SECONDARY TO DAPC DISSOCIATION
-
批准号:8168343
-
项目类别:
-
资助金额:$4.97万
-
财政年份:2010
-
负责人:STEPHEN C ARMSTRONG
-
依托单位:
SD COBRE: CELL IMAGING CORE
-
批准号:8168339
-
项目类别:
-
资助金额:$12.13万
-
财政年份:2010
-
负责人:STEPHEN C ARMSTRONG
-
依托单位:
INCREASED A7/B1 INTEGRIN SIGNALING SECONDARY TO DAPC DISSOCIATION
-
批准号:7959742
-
项目类别:
-
资助金额:$21.83万
-
财政年份:2009
-
负责人:STEPHEN C ARMSTRONG
-
依托单位:
SD COBRE: CELL IMAGING CORE
-
批准号:7959738
-
项目类别:
-
资助金额:$12.39万
-
财政年份:2009
-
负责人:STEPHEN C ARMSTRONG
-
依托单位:
SD COBRE: CELL IMAGING CORE
-
批准号:7720650
-
项目类别:
-
资助金额:$10.43万
-
财政年份:2008
-
负责人:STEPHEN C ARMSTRONG
-
依托单位:
MYOCARDIAL INTERCALATED DISKS
-
批准号:7610338
-
项目类别:
-
资助金额:$0.37万
-
财政年份:2007
-
负责人:STEPHEN C ARMSTRONG
-
依托单位:
SD COBRE: CELL IMAGING CORE
-
批准号:7381828
-
项目类别:
-
资助金额:$9.46万
-
财政年份:2006
-
负责人:STEPHEN C ARMSTRONG
-
依托单位:
Myocardial ischemic activation of the Akt pathway
-
批准号:7083537
-
项目类别:
-
资助金额:$27.02万
-
财政年份:2004
-
负责人:STEPHEN C ARMSTRONG
-
依托单位:
Myocardial ischemic activation of the Akt pathway
-
批准号:6817457
-
项目类别:
-
资助金额:$27.67万
-
财政年份:2004
-
负责人:STEPHEN C ARMSTRONG
-
依托单位:
Myocardial ischemic activation of the Akt pathway
-
批准号:7247821
-
项目类别:
-
资助金额:$26.23万
-
财政年份:2004
-
负责人:STEPHEN C ARMSTRONG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: